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The vocal folds are a remarkably unique tissue in the body, in that they can produce 
vibration at rates between 100-1000 hertz throughout the course of a day (Guimaraes & 
Abberton, 2005; Hunter et al., 2006). When this robust tissue is disrupted by scarring 
associated with vocal fold lesion excision, carcinoma, radiation, trauma, or inflammatory 
disease, the associated degradation in vocal quality can be devastating.  More than half of 
individuals with voice disorders attribute their dysphonia as having a negative impact on 
their social interactions, career and mental health (Smith et al., 1995).  Traditional surgical 
treatments and voice therapy have been suboptimal for improving the dysphonia and 
fatigue associated with vocal fold scarring (Hansen & Thibeault, 2006). Over the past 
decade, a number of promising pre-clinical studies targeted at vocal fold regeneration using 
mesenchymal stem cells (MSCs) have been completed.  As nearly all of the dedicated stem 
cell investigation has been completed in vitro and in animal models, there exists a great 
opportunity for innovation and landmark work in the future of this field. Our intention is to 
present the therapeutic interventions explored in the literature to date for mesenchymal 
stem cell (MSC) based approaches for vocal fold regeneration, in order to inform optimal 
approaches of the future.  
2. Key aspects of vocal fold function 
2.1 Basic cellular constitution of the vocal mucosa 
The vocal folds have a defined multilayered structure; whereby the vocal mucosa, made up 
of the epithelium, basement membrane zone and superficial lamina propria, is anchored to 
the underlying intermediate and deep layers of the lamina propria and thyroartenoid 
muscle. The vocal mucosa vibrates during phonation and is the most common site for injury 
and scarring.  As such, the anatomical target of the majority of bioengineered constructs for 
the larynx is the vocal mucosa. The lamina propria is home to fibroblasts, myofibroblasts 
and macrophages, and the epithelium contains epithelial cells and some dendritic cells that 
gain entry via the basement membrane zone (Catten et al., 1998). Due to their abundance 
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and the utility of their unique functions, the two cell types of primary interest for vocal fold 
tissue engineers are epithelial cells and vocal fold fibroblasts.  The vocal folds are covered by 
stratified squamous epithelium, which serves as a protective barrier against chemical, 
pathogenic and mechanical insults (Sivasankar et al., 2010; Mogi et al., 1979; Gray & Titze, 
1988; Gipson et al., 1995; Johnston et al., 2003). Laryngeal epithelial cells also help maintain 
local hydration, which is essential for healthy voice production (Fisher et al., 2001). The most 
abundant cell type in the lamina propria is the vocal fold fibroblast. These cells are largely 
evenly spread throughout the depth of the tissue (Catten et al, 1998). During a wound 
healing response, vocal fold fibroblasts migrate to the site  of injury and remodel the tissue 
by generating extracellular matrix (ECM) (Hirano et al., 1999).  
2.2 Basic ECM constitution of the vocal mucosa 
The ECM profile determines the biomechanical properties of vocal fold tissue, which, in 
turn, influences vocal quality (Thibeault et al., 2002).  Vocal fold scarring can be identified 
by the fibrotic conversion of the native ECM (Benninger et al., 1996).  While this later phase 
in injury and repair processes is innate, it can have a deleterious effect on vocal quality by 
altering the viscoelasticity of the tissue.  As such, vocal fold bioengineers must utilize cell 
sources, scaffolds, and growth factors that will remodel ECM profiles to mimic the 
viscoelasticity of healthy tissue. Accurate measurement of the elastic properties of vocal fold 
mucosa is difficult due to its small size and difficult to access location.  Investigators have 
used various models (cadaveric human larynges, in vivo and ex vivo canine larynx, etc) and 
techniques (nerve stimulation, parallel plate rheometry, indentation, etc), and have reported 
a range of shear moduli results (Hirano, 1981; Chhetri et al., 2010).  
The layered structure of vocal fold tissue can be defined by its relative constituent makeup; 
the vocal fold mucosa is primarily composed of ECM, and the underlying thyroartenoid is 
largely composed of cells (Gray et al., 2000b).  The robust ECM of the vocal fold mucosa is 
made up of fibrous proteins (i.e., collagens, elastins), interstitial proteins (i.e., hyaluronic 
acid, decorin, fibromodulin, decorin, versican) and other molecules such as lipids and 
carbohydrates.  
The fibrous proteins of the vocal fold ECM have traditionally received a large amount of 
attention, as they contribute significantly to viscoelasticity. Collagens provide tensile 
strength to vocal fold tissue. The lamina propria hosts collagen type I, II and III and the 
basement membrane zone contains type IV and VII (Gray, et al., 1993; Mossallam, et al., 
1986; Courey, et al., 1996; Gray, 1991). Elastins afford vocal tissue the ability to be stretched 
and then return to its original shape. The interstitial proteins are found between the 
collagens and elastins, and provide a variety of functions to the tissue. The large size, porous 
quality and high water content of hyaluronic acid (HA) are thought to offset the chronic 
vibration associated with phonation via shock absorption (Gray et al., 1999). HA also affects 
the viscosity of tissue, as a higher content corresponds to a higher tissue viscosity.  Decorin 
and fibromodulin also have a role in wound healing, as they are able to bind to collagen and 
regulate fibril synthesis (Gray, et al., 1999). Versican has an ability to bind water molecules 
and plays a role as a space-filler in the lamina propria (Gray, 2000b).  
ECM remodeling in the vocal folds is a finely coordinated, complex process, which is not yet 
fully understood.  Further investigation into how to modulate this process following injury 
is warranted. 
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3. Therapeutic interventions explored to date 
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Table 1. Animal models for vocal fold regeneration using MSCs 
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MSCs have many favorable characteristics, including an ability to migrate to a site of injury 
and to encourage proliferation and differentiation of progenitor cells. They have also been 
shown to exert control over the microenvironment via secretion of growth factors and 
matrix remodeling (Caplan, 2007; Uccelli et al., 2007).  There is evidence that the activity of 
T-lymphocytes, B-lymphocytes, and natural killer cells can be inhibited by MSCs, which 
suggests their potential allogeneic use without risk of immune response (Le Blanc & 
Ringden, 2007; Rasmussen et al., 2007). Interestingly, bone marrow derived mesenchymal 
stem cells (BM MSCs), adipose derived mesenchymal stem cells (ASCs) and human vocal 
fold fibroblasts found in the lamina propria demonstrate similar immunophenotypic 
properties, differentiation potential and cell surface markers (Long et al., 2009; Puissant et 
al., 2005; Hanson et al., 2010).  This shared cell surface profile included a positive expression 
for MSC markers (i.e., CD29, CD44, CD73, CD90 and CD105) and a negative expression for 
hematopoietic stem cell markers (i.e., CD14, CD31, CD34, CD45). Additionally, BM MSCs 
and ASCs have been shown to differentiate down epithelial and fibroblast lineages 
(Kanemaru et al., 2005; Long et al., 2009; Ohno et al., 2009). Collectively, these findings 
support the use of BM MSCs and ASCs in future vocal fold regeneration interventions. 
Further inquiry distinguishing the utility of these two cell sources is necessary, as there have 
been no in vivo reports directly comparing them in laryngeal research. 
There have been a few reports of injecting MSCs directly into the vocal fold, without a 
scaffold or soluble factors, in order to encourage regeneration following injury (see Table 1).  
These in vivo animal models have generally used a common investigative paradigm, which 
involves first creating a lesion unilaterally or bilaterally in the membranous portion of the 
vocal fold. After a period of days to weeks which allows the mature scar to form, the 
investigator then injects the cell therapy into the scarred region. Outcomes are determined 
with morphological assessment to characterize the anatomical structure of the tissue, 
rheometric analysis to determine the tissue’s viscoelasticity, and/or with gene or protein 
expression levels to analyze extracellular matrix component production. 
Measures of tissue biomechanics may be the most meaningful outcome to report in vocal fold 
literature, as viscoelasticity is known to significantly affect voice quality and patient outcomes. 
Thus, rheometric assessment is becoming an important functional measure in laryngeal 
literature.  Improved viscoelastic measures have been reported for vocal folds treated with BM 
MSCs alone in a rabbit model (Hertegård et al., 2006a; Svensson et al., 2010).  
Improved tissue morphology (less granulation tissue, less rough vocal fold edge) has been 
reported in injured vocal folds treated with BM MSCs as compared with controls, over a 
recovery periods lasting from four and twelve weeks (Hertegård et al., 2006a; Kanemaru et 
al., 2005, Svensson et al., 2010). Figure 1 demonstrates the resolution of one dog’s granuloma 
and rough vocal fold morphology over a 24 week recovery period. 
Protein and gene expression analysis can provide useful information about signaling 
pathways and ECM production. The literature to date has focused largely on the expression 
and some quantification of the ECM components known to be involved with wound 
healing, such as collagen, fibronectin, and hyaluronic acid. A reduction in collagen I content 
(Hertegård et al., 2006a, Svensson et al., 2010) and an increase in TGF-β1 production 
(Quinchia-Johnson et al., 2010) have been reported in vocal folds injected with BM MSCs 
alone versus scarred, untreated controls.  Additionally, it has been found in vitro that a co-
culture of ASCs and scar fibroblasts (SF) had decreased collagen production levels and 
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Fig. 1. Reprinted from Cells Tissues and Organs, Vol. 184/No. 3-4. Lee., B.Y., Wang, S.G., Lee, 
J.C., Jung, J.S., Bae, Y.C., Jeong, H.J., Kim, H.W., Lorenz, R.R. The prevention of vocal fold 
scarring using autologous adipose tissue-derived stromal cells, pp. 198-204, (2006), with 
permission from S Karger AG, Basel. Improved vocal fold morphology was observed in the 
scarred, treated right vocal fold, as compared with the scarred, untreated left vocal fold. a: 
On day 4, bilateral vocal fold lesions (see arrows) were created via electrocautery. b: On day 
14, edema noted in right vocal fold, with irregular vocal mucosa noted in left vocal fold. c: 
On day 28, granuloma was larger on the left than on the right. d: On day 57, right-sided 
granuloma has resolved, but left-sided granuloma remains. e: During week 24, the authors 
noted the appearance of scarring in the left vocal fold, but not in the right vocal fold. 
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SF proliferation rates when compared with SFs in monoculture (Kumai et al., 2009).  These 
data suggest that BM MSCs and ASCs support an anti-fibrotic profile when exposed to a 
scar environment.  Further protein and gene expression investigation is needed to uncover 
signaling pathways that may allow future bioengineers to control these processes. 
An optimal cell source to remediate vocal fold scarring and promote regeneration would be 
non-immunogenic, remain viable amidst significant vibration, migrate to the site of injury, 
encourage remodeling of ECM to reduce the fibrotic scar profile and efficiently differentiate 
into vocal fold fibroblasts and epithelial cells.  To date, a handful of initial studies have 
indicated the therapeutic potential of injecting BM MSCs or ASCs alone for vocal fold 
regeneration, but further characterization using the above criteria may prove useful. 
Investigation using pluripotent cells (embryonic stem cells, induced pluripotent stem cells) 
and MSCs isolated from other sources (i.e., spleen, thymus, umbilical cord blood, amniotic 
fluid and dental pulp) may also be considered. 
3.2 Scaffolds without cells 
Scaffold materials have long been used in injection laryngoplasty procedures by 
otolaryngologists for the treatment of patients with vocal fold paresis, paralysis or anatomical 
defects. In this treatment, the biomaterial/scaffold is primarily used as a bulking agent to push 
the affected vocal fold toward midline and allow for a closer physical approximation  
during phonation. Synthetic materials (silicone, polytetrafluoroethylene-Teflon, 
polyhydroxyethylmethacrylate) have largely been eschewed for clinical use because of their 
propensity for foreign body response, migration of material and non-biodegradability (Ejnell 
et al., 1984; Nakayama et al., 1993). These materials have been replaced in the clinic by more 
degradable biomaterials, such as collagen matrix (Kriesel et al., 2002) and fat (McCulloch et al., 
2002; Lo Cicero et al., 2008). These materials have viscoelastic properties more similar to vocal 
mucosa than the previous injectables. Additionally, the site of injection has changed from the 
thyroartenoid muscle to the lamina propria.   
Interestingly, it has recently reported that abdominal adipose tissue harvested for clinical 
use as a fat injection contains a local population of MSCs. These stem cells have a high 
proliferative potential and the ability to differentiate down multiple lineages (Lo Cicero et 
al., 2008).  These data suggest that a resident MSC population in vocal fold fat injections may 
contribute to long-term graft survival, which is suspected to occur in 55-100% of patients 
(McCulloch et al., 2002; Lo Cicero et al., 2008).  
Commercially available composite materials have also been commonly used in clinic, such 
as Gelfoam paste (Schramm et al., 1978), Cymetra (Milstein et al., 2005), calcium 
hydroxylapatite (Rosen et al., 2007), Restylane and Hylaform (Hertegard et al., 2006b).  
While these materials have all been reported to improve vocal function, they are not 
traditionally thought to grow and remodel the tissue, as many of them biodegrade in the 
body. Resorption is an advantage for patients with temporary vocal fold pathology and for 
those interested in a short-term trial, but it is a significant limitation for patients that are 
interested in long-term treatment, as they can necessitate repeated injections.  
A promising line of research is the investigation of gels and hydrogels as vocal fold 
injectables, as they may offer greater potential for vocal fold regeneration and improved 
viscoelastic properties over current scaffold materials. To date, hydrogels have primarily 
been HA based (Duflo et al., 2006a, Duflo et al., 2006b, Jia et al., 2004)  and collagen based 
(Hahn et al., 2006).  Figure 2 demonstrates the distinct rheometric measurements obtained 
from four treatment groups that included a semi-synthetic gel matrix (Thibeault et al., 2009). 
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Fig. 2. Reprinted from Tissue Engineering Part A, Vol. 15/No. 7, Thibeault, S.L., Klemuk, S.A., 
Smith, M.E., Leugers, C., Prestwich, G. In vivo comparison of biomimetic approaches for 
tissue regeneration of the scarred vocal fold, 1481-1487, (2009), with permission from Mary 
Ann Liebert, Inc. Using a stress-controlled rheometer, the authors were able to demonstrate 
distinct elastic and viscous moduli associated with the four treatment groups. 
Decellularized xenogeneic matrices derived from porcine small intestine, urinary bladder 
and bovine vocal fold tissue have also been investigated as potential laryngeal scaffolds 
(Ringel et al., 2006; Xu et al., 2007). In this model, the tissue is decellularized, leaving the 
potential for ECM-based repair of native via release of endogenous growth factors and 
activation of local cells.  
3.3 Scaffolds with cells 
There are many well characterized biomaterials used for injection laryngoplasty, though, 
only a few substances (i.e., HA based hydrogels, atelocollagen, fibrin) have been 
investigated for use as scaffolds in vocal fold MSC based therapies (Long et al., 2009; 
Kanemaru et al., 2003; Lee et al., 2010; Quinchia-Johnson et al., 2010; Ohno et al., 2009).  
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Fig. 3. Reprinted from The Laryngoscope, Vol. 120/No. 3, Quinchia-Johnson, B.H., Fox, R., 
Chen, X., Thibeault, S.L. Tissue regeneration of the vocal fold using bone marrow 
mesenchymal stem cells and synthetic extracellular matrix injections in rats, pp. 537-545, 
(2010), with permission from  John Wiley and Sons (publisher). More BM MSCs tagged with 
green fluorescent protein (shown in red) remain in the tissue 30 days postinjection for the 
combination therapy than the cells alone condition. 
HA based hydrogels have been shown to be noninflammatory, nonimmunogenic and 
biocompatible, as well as have significant shock absorption ability. Carbylan-GSX (a thinly-
modified semisynthetic GAG derived of HA mixed with a thiolated gelatin, and cross linked 
with polyethylene glycol), has viscoelastic properties similar to vocal mucosa when injected 
in vivo  (Duflo et al., 2006a). When encapsulated in Extracel, BM MSCs maintained a high 
viability (96% or better), and were able to sustain their cell growth over a three day period 
(Duflo et al., 2006b). They remained alive 30 days post injection (See Fig. 3). In addition, this 
construct injected in vivo produced an ECM profile more supportive of wound healing (i.e., 
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increased expression of fibronectin and pro-collagen III) than a cells only approach and the 
control condition (Quinchia-Johnson et al., 2010).  
Atelocollagen, a biomaterial found in a few recent reports, is derived from calf dermis and 
can be degraded in vivo by endogenous collagenase at a slower rate than collagen scaffolds.  
It can be used for tissue engineering purposes in an unmodified form (Lee et al., 2006), made 
into a sponge (Ohno et al., 2009) or into a gel (Kanemaru et al., 2003). Adherence of cells to 
the material is an important criterion for potential scaffold biomaterials. Approximately 20% 
of BM MSCs initially adhered to an atelocollagen sponge in vitro, with significant 
proliferation noted on days 3 and 5 (Ohno et al., 2009). The authors credited the cellular 
entry to the large pore size. BM MSCs labeled with a fluorochrome and seeded within a 1% 
hydrochloric acid atelocollagen gel were found to have “good proliferation” in vitro 
(Kanemaru et al., 2003).  Similarly, “ a large number” of fluorochrome-labeled cells were 
observed in canine vocal folds eight weeks after having been injected with ASCs within an 
atelocollagen scaffold (Lee et al., 2006). Despite this, atelocollagen has the distinct 
disadvantage of being an animal derived substance, which brings with it the threat of 
immune response activation or transmission of an endogenous retrovirus.  
A third reported scaffold biomaterial for vocal fold stem cell applications is fibrin.  Long et 
al. (2009, 2010) was able to demonstrate in vitro that a fibrin-based construct seeded with 
ASCs have good physical integrity and handling characteristics, slow degradation patterns 
and an ability to support cell viability. Recent findings demonstrate that these constructs 
have the elastic modulus and collagen orientation similar to native vocal mucosa, and are 
able to withstand oscillation when sutured onto an excised cadaveric larynx on top of pipe 
through which air can flow (Long et al., 2010).  See Figure 4. 
 
 
Fig. 4. Reprinted from Otolaryngology-Head and Neck Surgery, Vol. 142 /No. 3, Long, J.L., 
Neubauer, J., Zhang Z., Zuk, P., Berke, G.S., Chhetri, D.K. Functional testing of a tissue-
engineered vocal fold cover replacement, 438-440, 2010, with permission from Elsevier. 
Native vocal fold cover of cadaveric larynx has been replaced with a tissue engineered 
construct and vibrated with air from an underlying pipe. Arrows mark the edges of the 
construct. The top of images is the anterior commissure. These images were captured with a 
high speed camera. 
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An optimal scaffold for stem cell applications for vocal fold regeneration would be 
noninflammatory, nonimmunogenic, encourage adherence and viability of resident cells, 
support appropriate cell-cell signaling, biodegrade at an acceptable rate, remain intact 
during investigator handling, as well as be able to sustain vocal fold vibration. The scaffold 
materials listed previously have demonstrated some of these attributes in animal models, 
but applications in conjunction with stem cell approaches is scant, currently.  There exists a 
great opportunity to advance vocal fold regeneration strategies by finding an optimal 
scaffold to deliver cells and growth factors. 
3.4 Growth factor delivery 
To date, the delivery of only a few growth factors, including epidermal growth factor (EGF) 
fibroblast growth factor (FGF) and hepatocyte growth factor (HGF) have been investigated 
within MSC-based therapies for vocal fold regeneration. All of this work has been 
completed in vitro.   
The effect of soluble signaling has been used to examine the differentiation potential of 
ASCs. A bilayered, three dimensional construct was created in vitro by seeding ASCs within 
fibrin hydrogels, and once gelation was complete, additional ASCs were added directly on 
top. When EGF, FGF and retinoic acid were added to the media surrounding these 
constructs, it was found that EGF encouraged differentiation of ASCs into epithelial cells  
more efficiently than the other soluble signals (Long et al., 2009).  The authors found that the 
cells on the top, epithelial-like surface stained positive for E-cadherin and cytokeratin 8, 
epithelial phenotype markers. It was found that these cells differentiated along this lineage 
only when they had an air interface and exposure to EGF.  Interestingly, the authors 
hypothesized that mechanotransduction may have also played a role in differentiation, as 
the cells were cultured on a matrix with similar stiffness to the lamina propria. The cells on 
the inside of the hydrogel stained positive for vimentin, a cytoskeletal protein expressed by 
cells of mesenchymal origin. It should be noted that during the two week culture period, the 
epithelial cells did not form a confluent layer, suggestive of reduced efficiency of 
differentiation and proliferation of epithelial cells. 
HGF is known to have strong anti-fibrotic activity, and has been investigated in the voice 
literature as a stand-alone injection to remediate vocal fold scarring in an animal model 
(Hirano et al., 2004).  In this study, the HGF treated vocal folds had improved rheometric 
measurements and less collagen deposition than the scarred, untreated vocal folds. In the 
MSC literature, HGF has been implicated as being secreted by ASCs and encouraging an 
anti-fibrotic extracellular matrix profile when they are in co-culture with scar fibroblasts 
(Kumai, 2009).  Following vocal fold scarring, ASCs and scar fibroblasts (SF) were isolated 
from male ferrets, and then co-cultured in a variety of conditions to investigate their 
relationship with HGF. In order to demonstrate that HGF was one of the growth factors 
implicated in reducing the production of collagen, a neutralization assay was used. 
Following four days of co-culture of ASCs and SFs with an anti HGF antibody in the 
medium, the SFs had significantly higher amounts of collagen secretion than in the control 
condition. This condition did not affect HA secretion, and thus it was concluded that the 
HGF secreted by ASCs encourages the anti-fibrotic profile of SFs by downregulating 
collagen production, but not by upregulating HA production. Additionally, the authors 
suggested that a tissue engineering construct delivering HGF through ASCs to the vocal 
fold microenvironment rather than through an exogenous agent is preferable because of the 
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slow release associated with having residency in the tissue and the potential activation of 
concurrent endogenous facilitatory factors. So, while there have been few studies of 
introducing growth factors exogenously to tissue engineering for vocal fold regeneration, 
endogenous growth factors are often thought to be present. 
4. Future directions 
4.1 Bioreactors 
Bioreactors provide ex vivo mechanical stimulation that mimics a specific tissue’s 
microenvironment for cells in media.  With regard to laryngeal research, bioreactors can 
provide a unique model for studying the effects of vibration (similar to phonation) on cells 
in a controlled environment.  For the custom designed bioreactors currently used in this line 
of research, frequency, amplitude and duration of vibration and tension of the substrate 
which cells are adherent to can often be programmed according to the experimental 
question of interest.  There are many potential applications of this technology, including 
examination of the effects of dosage of vibration on cells of various laryngeal diseases, 
investigation of scar fibroblast activity at varying time intervals post laryngeal surgery (to 
inform recommendations about when to resume voicing post-operatively) and to compare 
the effects different laryngeal configurations during phonation on healing (to mimic 
different voice therapies at the cellular level), etc.   
While there have been several reports of the effects of stem cell therapies on ECM 
production, few studies have investigated the mechanisms for encouraging specific vocal 
fold ECM profiles. Bioreactors may provide a mode of inquiry toward these ends. 
Interestingly, recent literature suggests that fibroblasts are able to convert mechanical 
stimuli into ECM modifications, and thereby induce tissue remodeling via 
mechanotransduction (Ingber, 2006). Recent voice research using bioreactors have found 
significant vibration induced changes in the ECM profile. For example, human dermal 
fibroblasts vibrated in hydrogels for periods of five and ten days demonstrated increased 
expression of HA synthase 2, decorin and fibromodulin (Kutty & Webb, 2010). Human 
laryngeal fibroblasts vibrated for periods between 1-21 days showed an increased 
production of fibronectin and collagen type I (Wolchok et al., 2009). Finally, human vocal 
fold fibroblasts vibrated for 6 hours showed an upregulation of fibronectin and HA-
associated genes (Titze et al., 2004). Comparison of the ECM produced by multiple cell types 
exposed to vibration that mimics phonation may help scientists determine an optimal cell 
source for vocal fold bioengineering. 
Currently bioreactors provide a research model, but in the future they may be utilized in 
therapeutic inventions.  It may be found that cells can be primed in a bioreactor to create an 
optimal ECM profile before they are implanted into an organism with scarring or other 
vocal pathology. The use of bioreactors is a promising line of research that could shape 
future tissue regeneration approaches.   
5. Conclusion 
The regenerative potential of vocal fold tissue is a topic that is currently being investigated 
by an increasing number of teams internationally. While the literature to date has merely 
scratched the surface of the basic parameters involved in laryngeal tissue engineering, there 
is great opportunity for advancement of the knowledge base with the advent of high 
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throughput experimental techniques, systems biology approaches and their associated 
statistical analysis. These developments allow for more efficient and comprehensive 
assessments of cell/scaffold interactions and ECM production profiles. Current themes in 
the literature include morphological and rheological outcomes of cell based therapies and 
how to use scaffolds and bioreactors to encourage optimal ECM regeneration. Future topics 
may include how to encourage efficient differentiation into epithelial cells via signaling 
mechanisms, how to engineer confluent and distinct layers that mimic normal vocal fold 
anatomy, how to induce angiogenesis that will be able to withstand vibration without 
hemorrhage and how to innervate the tissue.  
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